Carcinoid heart disease: Case and literature review

Acta Cardiologica

Volumn 65, Issue 2, 2010, Pages 261-264

  Dumoulein, Michiel ^a   Verslype, Chris ^a   Van Cutsem, Eric ^a   Meuris, Bart ^a   Herijgers, Paul ^a   Flameng, Willem ^a   Herregods, Marie Christine ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Carcinoid syndrome; Heart failure; Neuroendocrine tumour; Tricuspid regurgitation

Indexed keywords

ALPHA INTERFERON; OCTREOTIDE;

AGED; ANKLE EDEMA; ARTICLE; CARCINOID SYNDROME; CASE REPORT; CENTRAL VENOUS PRESSURE; CLINICAL EXAMINATION; DILATATION; DISEASE COURSE; DRUG DOSE ESCALATION; DYSPNEA; FEMALE; FLUSHING; HEART FAILURE; HUMAN; ILEUM; INFERIOR CAVA VEIN; LIVER METASTASIS; MITRAL VALVE REGURGITATION; NEUROENDOCRINE TUMOR; PLEURA EFFUSION; PROGNOSIS; PULMONARY HYPERTENSION; SYSTOLIC HEART MURMUR; TRANSTHORACIC ECHOCARDIOGRAPHY; TRICUSPID VALVE REGURGITATION; VALVULAR HEART DISEASE; WEIGHT REDUCTION;

AGED; CARCINOID HEART DISEASE; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FEMALE; HUMANS; PROGNOSIS; SEVERITY OF ILLNESS INDEX; TRICUSPID VALVE; TRICUSPID VALVE INSUFFICIENCY;

EID: 77951541796     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.65.2.2047065     Document Type: Article

References (19)

1. Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer 1997; 79: 813-829. (Pubitemid 27076348)
2. Fox DJ, Khattar RS. Carcinoid heart disease: presentation, diagnosis and management. Heart 2004; 90: 1224-1228. (Pubitemid 39279919)
3. Westberg G, Wangberg B, Ahlman H, Bergh CH, Beckman-Suurküla M, Caidahl K. Prediction of prognosis by echocardiography in patients with midgut carcinoid syndrome. Br J Surg 2001; 88: 865-872. (Pubitemid 32823842)
4. Pellikka PA, Tajik AJ, Khandheria BK, Seward JB, Callahan JA, Pitot HC, Kvols LK. Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients. Circulation 1993; 87: 1188-1197.
5. Connolly HM, Schaff HV, Mullany CJ, Rubin J, Abel MD, Pellikka PA. Surgical management of left-sided carcinoid heart disease. Circulation 2001; 104: I-36-I-40. (Pubitemid 32884774)
6. Lundin L, Norheim I, Landelius J, Oberg K, Theodorsson-Norheim E. Carcinoid heart disease: relationship of circulating vasoactive substances to ultrasound-detectable cardiac abnormalities. Circulation 1988; 77: 264-269. (Pubitemid 18060033)
7. Pandya U, Pellikka P, Enriquez-Sarano M, Edwards WD, Schaff HV, Connolly HM. Metastatic carcinoid tumor to the heart: echocardiographic-pathologic study of 11 patients. J Am Coll Cardiol 2002; 40: 1328-1332.
8. Simula DV, Edwards WD, Tazelaar HD, Connolly HM, Schaff HV. Surgical pathology of carcinoid heart disease: a study of 139 valves from 75 patients spanning 20 years. Mayo Clin Proc 2002; 77: 139-147.
9. Robiolio PA, Rigolin VH, Wilson JS, Harrison JK, Sanders LL, Bashore TM, Feldman JM. Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography. Circulation 1995; 92: 790-795.
10. Zuetenhorst JM, Bonfrer JM, Korse CM, Bakker R, van Tinteren H, Taal BG. Carcinoid heart disease: the role of urinary 5-hydroxyindoleacetic acid excretion and plasma levels of atrial natriuretic peptide, transforming growth factor-beta and fibroblast growth factor. Cancer 2003; 97: 1609-1615. (Pubitemid 36350703)
11. Connolly H, Crary J, McGoon M, Hensrud DD, Edwards BS, Edwards WD, Schaff HV. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med 1997; 337; 581-588. (Pubitemid 27360757)
12. Zanettini, R, Antonini, A, Gatto, G, Gentile R, Tesei S, Pezzoli G. Valvular heart disease and the use of dopamine agonists for Parkinson's disease. N Engl J Med 2007; 356: 39-46. (Pubitemid 46041752)
13. Schade R, Andersohn F, Suissa S, Haverkamp W, Garbe E. Dopamine agonists and the risk of cardiac-valve regurgitation. N Engl J Med 2007; 356: 29-38. (Pubitemid 46041751)
14. Gustafsson B, Tommeras K, Nordrum I, Loennechen JP, Brunsvik A, Solligård E, Fossmark R, Bakke I, Syversen U, Waldum H. Long-term serotonin administration induces heart valve disease in rats. Circulation 2005; 111: 1517-1522. (Pubitemid 40470647)
15. rd. Echocardiographic and biochemical evaluation of the development and progression of carcinoid heart disease. J Am Coll Cardiol 1998; 32: 1017-1022.
16. Connolly HM, Nishimura RA, Smith HC, Pellikka PA, Mullany CJ, Kvols LK. Outcome of cardiac surgery for carcinoid heart disease. J Am Coll Cardiol 1995; 25: 410-416.
17. Moller JE, Pellikka PA, Bernheim AM, Schaff HV, Rubin J, Connolly HM. Prognosis of carcinoid heart disease: analysis of 200 cases over two decades. Circulation 2005; 112: 3320-3327. (Pubitemid 43739378)
18. Ridker PM, Chertow GM, Karlson EW, Neish AS, Schoen FJ. Bioprosthetic tricuspid valve stenosis associated with extensive plaque deposition in carcinoid heart disease. Am Heart J 1991; 121: 1835-1838.
19. Schoen FJ, Hausner RJ, Howell JF, Beazley HL, Titus JL. Porcine heterograft valve replacement in carcinoid heart disease. J Thorac Cardiovasc Surg 1981; 81: 100-105. (Pubitemid 11217352)